PP
ORGO icon

PDT Partners’s Organogenesis Holdings ORGO Stock Holding History

PDT Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,468
Closed -$149K – 799
2025
Q1 		$149K Hold
34,468
– – 0.01% 696
2024
Q4 		$110K Buy
+34,468
New +$116K 0.01% 688
2022
Q4 		– Sell
-83,598
Closed -$271K – 820
2022
Q3 		$271K Sell
83,598
-37,857
-31% -$171K 0.04% 626
2022
Q2 		$593K Buy
121,455
+75,734
+166% +$466K 0.05% 557
2022
Q1 		$348K Buy
+45,721
New +$354K 0.03% 675
2021
Q3 		– Sell
-160,067
Closed -$2.66M – 875
2021
Q2 		$2.66M Buy
+160,067
New +$2.98M 0.18% 236

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's ORGO Position: Q2 2025 in Review

PDT Partners sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 34,468 shares — an estimated $149K sold.

PDT Partners first reported a position in ORGO in Q2 2021 and held it in 6 quarters. The position peaked at $2.66M in Q2 2021. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • PDT Partners reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 34,468 Organogenesis Holdings shares in Q2 2025, an estimated $149K.
  • PDT Partners first reported a position in Organogenesis Holdings in Q2 2021 and held it in 6 quarters.
  • PDT Partners's Organogenesis Holdings position peaked at $2.66M in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.